Pilot Study on MAGE-C2 as a Potential Biomarker for Triple-Negative Breast Cancer

Objective. In the current study, we measured the expression status of melanoma antigen gene c2 (MAGE-C2) in triple-negative breast cancer (TNBC) and analyzed its prognostic with the clinical pathological features of patients with TNBC. Methods. The expressions statuses of MAGE-C2 were detected in TN...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhao, Qian, Xu, Wen-ting, Shalieer, Tuluhong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5098074/
https://www.ncbi.nlm.nih.gov/pubmed/27843173
http://dx.doi.org/10.1155/2016/2325987

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5098074/
https://www.ncbi.nlm.nih.gov/pubmed/27843173
http://dx.doi.org/10.1155/2016/2325987

Ejemplares similares